Videos

Sun exposure can worsen hyperpigmentation and increase sensitivity in people using common acne medications like tretinoin and isotretinoin.

Urologist Loren Jones, M.D., explains why hot weather, concentrated urine and certain foods raise kidney stone risk, and why stones are increasingly common in young people.

From the anxiety rebound that follows a few drinks to the brain's remarkable ability to recover with sustained abstinence, psychiatrist Enrique Diaz, M.D., offers a clinically grounded and genuinely hopeful look at alcohol's effects on the brain.

NEA president and CEO Kristin Belleson explains what Living Well With Eczema, a free one-day event series, offers patients at every stage of their eczema journey.

New data show 57% of consumers want full ingredient transparency, and the FDA is pushing brands toward natural colors. Nico Saraceno breaks down what that shift means for patients and everyday food choices.

Sherrie Singh-Bryan, Pharm.D., addresses what patients should realistically expect when obesity medication stops, how to navigate rising cost barriers and why using medication for obesity is not the easy way out.

Sherrie Singh-Bryan, Pharm.D., explains why choosing the right obesity medication requires evaluating the whole patient, and why medication is just one of four essential pillars of lasting obesity treatment.

Brian Snelling, M.D., explains why stroke is increasingly affecting younger adults, why its subtle symptoms make it uniquely dangerous compared with a heart attack, and why the single most important thing anyone can do is call 911 the moment symptoms appear.

Edward Karpman, M.D., explains why low testosterone is a cardiovascular and bone health concern as much as a sexual one, and why GLP-1 medications represent the most significant innovation he has seen in men's health in his career.

Concluding the series, John Buse, M.D., Ph.D., details how cortisol directly promotes visceral belly fat distribution and appetite surges, while leaving patients with an empowering reminder that a stubborn A1C is a clinical puzzle to solve rather than a personal failure.

Rimal Bera, M.D., offers a practical road map for mental health advocacy in marginalized communities, from voting and school involvement to sharing openly with a primary care doctor and simply checking in on the people around you.

Rimal Bera, M.D., explains how chronic stress from racism and discrimination affects mental health in ways that are distinct, measurable and intergenerational, and why closing the mental health equity gap requires systemic change at every level from medical schools to law enforcement.

This episode explores the clinical nuances of utilizing cortisol-directed treatments like mifepristone to block hormone action, detailing the careful titration protocols required in practice and highlighting an upcoming explosion of novel therapies currently in clinical trials.

From the probability bias that leads physicians toward more common diagnoses to the geographic barriers that make a definitive workup inaccessible for many patients, Panagis Galiatsatos, M.D., lays out the systemic challenges behind the underdiagnosis of pulmonary hypertension.

Doris Wang, M.D., Ph.D., shares real-world results from long-term testing of her team's adaptive deep brain stimulation system, including reduced falls and patients who chose to stay on the adaptive setting long after the study ended.

Doris Wang, M.D., Ph.D., and her team developed a personalized adaptive deep brain stimulation system that detects gait-related brain signals and automatically adjusts stimulation in real time to help Parkinson's patients walk more steadily.

Unpack embarrassing gut symptoms, learn why “IBS” may mask Crohn’s, and see how honest talks, tests, and biologics lead to remission.

Embarrassing gut issues deserve answers: testing can uncover IBS or Crohn’s, and early biologic treatment helps achieve remission.

Panagis Galiatsatos, M.D., M.H.S., breaks down the five groups of pulmonary hypertension and why the psychological toll of a PAH diagnosis is particularly significant for younger patients.

The discussion maps out the critical diagnostic pipeline for patients, establishing the 1mg overnight dexamethasone suppression test as the gold-standard initial screener and explaining how subsequent testing identifies whether the hormone excess originates in the pituitary or the adrenal glands.

Joseph Volpicelli, M.D., Ph.D., explains why alcohol use disorder does not require hitting rock bottom to treat, and why a 30-year-old FDA-approved medication is still being overlooked by most physicians.

Addiction medicine expert Joseph Volpicelli, M.D., Ph.D., explains why alcohol use disorder remains so normalized, so stigmatized and so consistently undertreated in primary care settings.

FDA approves bemotrizinol, the first new U.S. sunscreen ingredient in decades, and a skin cancer specialist explains what makes it different.

Patient advocate Paul opens up about four decades of living with severe eczema, and why he is now speaking out during Men's Health Month to help others feel less alone.

Learn why controlling IBD matters more than feared side effects, and how biologics, monitoring, and whole-person care restore normal life.

Learn how IBD patients get fast access to Tremfya, navigate insurance, and stay in remission with ongoing tests and doctor teamwork.

Sandra Chaparro, M.D., breaks down why pulmonary arterial hypertension is so frequently underdiagnosed, what subtle symptoms patients should never ignore and why a multidisciplinary care team is essential to long-term outcomes.

Pediatric allergist and mom Vivian Hernandez-Trujillo, M.D., breaks down how early recognition and immediate epinephrine use can save lives, and why AUVI-Q's built-in guidance makes all the difference in a crisis.